From: Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal
Antibiotic | All patients | Sex | Age (years) | |||||
---|---|---|---|---|---|---|---|---|
Female | Male | <29 | 30–39 | 40–49 | 50–59 | >60 | ||
(n = 42) | (n = 26) | (n = 16) | (n = 10) | (n = 7) | (n = 11) | (n = 7) | (n = 7) | |
AMX | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
CAM | 9 (21.4) | 7 (26.9) | 2 (12.5) | 2 (20.0) | 2 (28.6) | 2 (18.2) | 1 (14.3) | 2 (28.6) |
MNZ | 37 (88.1) | 24 (92.3) | 13 (81.3) | 8 (80.0) | 6 (85.7) | 9 (81.8) | 7 (100.0) | 7 (100.0) |
TNC | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
LVX | 18 (42.9) | 10 (38.5) | 8 (50.0) | 6 (60.0) | 2 (28.6) | 3 (27.3) | 2 (28.6) | 5 (71.4) |